Funds raised in equity finance between June and August 2020
News
RPS calls for prevention of counterfeit medicines in UK’s supply chain
In a letter to Health Secretary Matt Hancock the RPS called for urgent action
Bavencio, Imbruvica among latest SMC decisions
The committee accepted a number of drugs through the PACE process
ViiV posts positive long-term data for two-drug HIV regimen Dovato
Dovato demonstrated non-inferior efficacy compared to TAF-based regimens
BMS’ Zeposia hits the mark in ulcerative colitis
Oral S1P receptor modulator hit both primary endpoints in a phase III trial
Pfizer’s Ibrance flunks early breast cancer trial
Therapy failed to improve invasive disease-free survival in high-risk patients
AZ’s long-acting COVID-19 antibody moves into phase III
Two trials will involve over 6,000 participants at sites in and outside the US
London universities join forces to ramp up COVID-19 testing
Testing Alliance created to offer 20,500 extra coronavirus tests a day
Neuroblastoma UK welcomes advancement of potential new treatment
Fadraciclib has passed safety trials and shown early efficacy
Amgen announces NHS collaboration aiming to tackle high cholesterol
Partnership will aim to prevent cardiovascular events across the North West Coast of England
European Commission scores 200 million doses of J&J’s potential COVID-19 vaccine
Advance purchase agreement follows initial exploratory talks
Charities unite to highlight pandemic’s disruption to cancer services
Twenty charities representing people affected by rare and less common cancers launch ’20 for 20′ campaign
ABPI calls on UK government to create non-COVID clinical research strategy
New report finds UK is leading on early-stage clinical trials but needs strategy to restart non-COVID research
First-ever Patient Partnership Index Conference takes place
Senior leaders from patient organisations and the pharma industry came together to discuss best practice in patient partnerships
Gilead inks supply agreement with the European Commission for remdesivir
New agreement allows countries in the EU, EEA and the UK to purchase drug
